Full text is available at the source.
Abstract
Short-chain fatty acids (SCFAs) may play a role in the relationship between gut microbiota alterations and depressive symptoms.
- Dysregulation of the microbiota-gut-brain axis is associated with depression.
- Immune and inflammatory signaling may connect changes in gut microbes to depressive symptoms.
- SCFAs like acetate, propionate, and butyrate are potential mediators of inflammation and neuroplasticity.
- Clinical trials regarding the therapeutic role of SCFAs have produced inconsistent results.
- This research aims to evaluate the link between SCFA levels and the severity of depressive symptoms.
Simplified